Switching Targets Best in RA Patients Who Fail Anti-TNFSwitching Targets Best in RA Patients Who Fail Anti-TNF

Changing the class of biologics is an effective strategy for most patients with rheumatoid arthritis (RA) who don't respond to their first anti-tumor necrosis factor (TNF) agent, new research shows. Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Rheumatology News Source Type: news